1 / 38

Introduction

Comparative quantitative evaluation of the XIAP, survivin & Ki67 transcript levels in urine & tissue samples of bladder cancer patients. Introduction. Bladder cancer (BCa)- 5th commonest cancer in European men & 6th leading cause of death

Download Presentation

Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Comparative quantitative evaluation of the XIAP, survivin & Ki67 transcript levels in urine & tissue samples of bladder cancer patients

  2. Introduction • Bladder cancer (BCa)- 5th commonest cancer in European men & 6th leading cause of death • Cystoscopy & urine cytology - current gold standards for diagnosis & surveillance of BCa • Ideal tumour marker for non-invasive diagnosis & surveillance does not yet exist

  3. Introduction • Survivin inhibitor of apoptosis protein (IAP) that is selectively over-expressed in most human malignancies • Objectives • determine suitability of survivin as diagnostic, surveillance (and prognostic) marker of BCa • compare the utility of survivin to other potential tumour markers e.g. Ki67 and XIAP

  4. Materials & Methods • Prospective study • Single, tertiary level referral centre • January - June 2006 • Inclusion criteria • patients undergoing transurethral resection (TUR) for newly diagnosed BCa, recurrent BCa & cystoscopically suspicious bladder lesions

  5. Materials & Methods • Exclusion criteria • Patients with PCa, IDC, UTI • Controls • BPH patients • Cystitis patients • Healthy volunteers

  6. Materials & Methods • BCa patients • Pre-operative urine sample • Intra-operative tumour tissue & “normal appearing” bladder mucosa • Post-operative urine sample (1 POD) • Above repeated for every session of TUR • Controls • 1 urine sample from each

  7. Materials & Methods • Quantitative evaluation of urinary & tissue levels of survivin, XIAP & Ki67 • Normalized ratios of survivin, XIAP & Ki67 correlated with clinicopathological data

  8. Results • Reference genes used – HPRT & TBP • Negative correlation between reference gene expression & urinary contamination by RBCs & WBCs

  9. BCa patients 65 recruited 6 pts with both BCa & Pca, excluded from analysis > 59 pts analysed Age (median)= 69yrs (34 – 89) M:F= 39: 20 (66.1% : 33.9%) Newly dx: BCa recurr= 54: 5 (91.5% : 8.5%) PSA (median; 36 pts)= 0.90 (0.16 – 12.54)

  10. BCa patients Stage @ diagnosis (59) • No tumour (11) 18.6% • Superficial (38) = Ta+T1 64.5% • Invasive (10) = T2 16.9% Grade @ diagnosis (59) • No tumour (11) 18.6% • Low (14) = G1 23.8% • High (34) = G2+G3 57.6%

  11. BCa patients • cis • Pos: neg= 5: 54 (8.5% : 91.5%) • All with cis harbour high grade (G2/ G3) disease as well • Cytology • Sensitivity= 65.2%; Specificity= 80.0% • PPV= 83.3%; NPV= 60.0%

  12. BCa patients • 59 primary TURBT 42 second op (33 sec TUR, 9 cystec) 8 third op (6 tertiary TUR, 2 cystec)

  13. Controls

  14. Tumor markers between BCa patients & controls Median values presented

  15. Ki67

  16. XIAP

  17. Survivin

  18. Tumor markers vs BCa stage Median values presented

  19. Ki67

  20. XIAP

  21. Survivin

  22. Tumor markers vs BCa grade Median values presented

  23. Ki67

  24. XIAP

  25. Survivin

  26. Tumor markers between first & second TURBT Median values presented

  27. Ki67

  28. XIAP

  29. Survivin

  30. Tumor markers for unpaired tissue samples Median values presented

  31. Ki67

  32. XIAP

  33. Survivin

  34. Tumor markers for paired tissue samples Median values presented

  35. Ki67

  36. XIAP

  37. Survivin

  38. Ratio Tu / Tf

More Related